Aller au contenu principal
Retour à l'annuaire
MM
RhumatologueMédecins généralistes et spécialistes👤 Libéral intégral

M. Docteur MATTHIAS MICHEL

📍 Calais (62)Mixte💶 Secteur 2RPPS 10100527158
📊 Reconnaissance scientifique : 24/100📝 70 articles publiés📚 HAL (8)🏆 1 DU/DIU

Diplômes

🎓 DES & spécialité ordinale

  • DES Rhumatologie

🏅 DU / DIU

  • DIU Médecine manuelle et Ostéopathie
  • DU ou DIU Ostéopathe d'une université de médecine reconnu par le CNOM

🎓 Diplômes

  • DE Docteur en médecine

Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.

🏆 Diplômes complémentaires reconnus

  • DIU Médecine manuelleDIU

    Formation médicale aux manipulations vertébrales et articulaires. Réservée aux médecins (vs ostéopathes non médecins). Très populaire en rhumato : 172 rhumatos formés en France.

    Plusieurs universités françaises

    Page d'information générale →

Activité de recherche & publications

Source : bases de données publiques (OpenAlex, PubMed).

h-index

24

h articles cités ≥ h fois chacun. Un h de 24 = 24 publications avec 24+ citations.

Citations

1 653

Publications

70

i10-index

28

Thématiques principales

  • Neural dynamics and brain function ×14
  • Visual perception and processing mechanisms ×12
  • Philosophy and Theoretical Science ×9
  • Neural and Behavioral Psychology Studies ×7
  • Embodied and Extended Cognition ×7
Voir sur OpenAlex ↗🆔 ORCID 0000-0002-5780-5702

Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.

Bibliographie

Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).

Localisation

Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.

Lieux de consultation

Tarifs & secteur de conventionnement

🟡 Secteur 2 — Honoraires libresSource CNAM (Annuaire santé Ameli)
✓ OPTAM💳 Carte VitaleLibéral intégral
📊 Comprendre le remboursement

Prendre rendez-vous & contact

🗓 Trouver sur Doctolib📇 Ajouter à mes contacts

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Top publications · les plus citées

  • 1
    The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases

    Blood · 2009

    📚 194 citations🎯 RCR 5.51Top 7% NIH🩺 Clinique🔓 Open Access📄 PDF gratuit ↗
    Lire l'abstract Crossref ↓

    Abstract Evans syndrome (ES) is a rare disease characterized by the simultaneous or sequential development of autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP) and/or immune neutropenia. To better describe the characteristics and outcome of ES in adults, a survey was initiated in 2005. The data from 68 patients (60% of them women) fulfilling strict inclusion criteria for ES are reported. The mean age at time of ITP and/or AIHA onset was 52 plus or minus 33 years, both cytopenias occurred simultaneously in 37 cases (54.5%). ES was considered as “primary” in 34 patients (50%) but was associated with an underlying disorder in half of the cases, including mainly systemic lupus, lymphoproliferative disorders, and common variable immunodeficiency. All patients were given corticosteroids, but 50 of them (73%) required at least one “second-line” treatment, including splenectomy(n = 19) and rituximab (n = 11). At time of analysis, after a mean follow-up of 4.8 years, only 22 patients (32%) were in remission off treatment; 16 (24%) had died. In elderly patients, the risk of cardiovascular manifestations related to AIHA seems to be higher than the ITP-related risk of severe bleeding. In conclusion, ES is a potentially life-threatening condition that may be associated with other underlying autoimmune or lymphoproliferative disorders.

  • 2
    Economic impact of lower-limb osteoarthritis worldwide: a systematic review of cost-of-illness studies

    Osteoarthritis and cartilage · 2016

    📚 154 citations🎯 RCR 7.88Top 4% NIH🔓 Open Access📄 PDF gratuit ↗
  • 3
    Characteristics and outcome of warm autoimmune hemolytic anemia in adults: New insights based on a single-center experience with 60 patients

    American journal of hematology · 2014

    📚 119 citations🎯 RCR 4.77Top 8% NIH🔓 Open Access📄 PDF gratuit ↗
    Lire l'abstract Crossref ↓

    Warm autoimmune hemolytic anemia (wAIHA) is a rare autoimmune disease with poorly known natural history and management remaining mainly empirical. To better describe the characteristics and outcome of wAIHA in adults, we performed a single‐center cohort study of patients diagnosed with wAIIHA from 2001 to 2012 in our center. Sixty patients (50% women) were included, the mean age at the time of wAIHA onset was 54 ± 23 years. wAIHA was considered “primary” for 21 patients (35%) and was associated with an underlying disorder in 39 (65%), including mainly lymphoproliferative disorders and systemic lupus. All patients but two needed treatment and received corticosteroids, with an overall initial response rate of 87%. However, 63% of the patients were corticosteroid‐dependent and 56% required at least one second‐line treatment including mainly rituximab (n = 19). At the time of analysis, after a mean follow‐up of 46 months, 28 patients (47%) were in remission and off treatment and 5 (8%) had died. The presence of an underlying lymphoproliferative disorder was associated with reduced response to corticosteroids and increased need for second‐line therapy. In conclusion, in the last decade and compared to a previous series from our center, the rate of secondary wAIHA has increased and the use of rituximab has emerged as the preferred second‐line treatment and corticosteroid‐sparing strategy; the overall mortality has significantly decreased (8 vs. 18%). Am. J. Hematol. 89:E150–E155, 2014. © 2014 Wiley Periodicals, Inc.

Publications scientifiques (50) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Transversal23

▼

Lupus6

▼

Biothérapies non-anti-TNF4

▼

Connectivite mixte3

▼

SAPL3

▼

Épidémiologie & registres2

▼

Revue générale2

▼

Anti-IL-231

▼

Anti-TNF1

▼

Case report / série1

▼

csDMARDs1

▼

Économie santé1

▼

Lombalgie1

▼

Ostéoporose1

▼

Pédiatrie1

▼

Pharmacovigilance1

▼

Revue / méta-analyse1

▼

Santé mentale / fatigue1

▼

Sclérodermie1

▼

Vascularites1

▼

Datasets & protocoles partagés

Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).

Partager cette fiche

in LinkedIn🟢 WhatsApp✉ Email

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.